Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
9.35
+0.10 (1.08%)
At close: Sep 15, 2025, 4:00 PM EDT
9.17
-0.18 (-1.93%)
After-hours: Sep 15, 2025, 5:25 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $492.78 million as of September 15, 2025. Its market cap has increased by 255.63% in one year.
Market Cap
492.78M
Enterprise Value
453.83M
1-Year Change
255.63%
Ranking
Category
Stock Price
$9.35
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $492.78M, an increase of 37.79%. That is a compound annual growth rate of 4.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 487.51M | -6.68% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | 7.40B | 134.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.83B |
| Johnson & Johnson | 430.35B |
| AbbVie | 383.68B |
| UnitedHealth Group | 313.08B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.99B |